| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 12/26/2001 | CN1328556A Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 12/26/2001 | CN1328555A Novel salts of pyridopyrazine compound and crystals thereof |
| 12/26/2001 | CN1328455A Use of N-substituted azabicycloalkane derivatives for treating diseases of central nervous system |
| 12/26/2001 | CN1328451A Drugs for improving vesical excretory strength |
| 12/26/2001 | CN1076744C Monophase solid solution containing asymmetric pyrrolo [4,3-C] pyrroles as hosts |
| 12/26/2001 | CN1076728C Derivative of 2-aryl imidazo [2,1-a] isoquinoline and its use |
| 12/25/2001 | US6333344 Prolines as antimicrobial agents |
| 12/25/2001 | US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics |
| 12/25/2001 | US6333336 Pyrazolo-pyridine derivatives as ligands for GABA receptors |
| 12/25/2001 | US6333335 To inhibit prenyl-protein transferase and the prenylation of the oncogene protein ras |
| 12/25/2001 | US6333296 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them |
| 12/25/2001 | CA2068590C Process and intermediates for the preparation of spiro¬isoquinoline-4(1h),3'-pyrrolidine|-1,2',3,5'(2h)-tetrones which are useful as aldose reductase inhibitors |
| 12/25/2001 | CA2053640C Quinoline derivatives |
| 12/25/2001 | CA2052424C 2-(4-piperidinyl)-1h-pyrido¬4,3-b|indol-1-ones and related compounds, intermediates and a process for their preparation |
| 12/20/2001 | WO2001096877A2 Rare earth metal cryptates showing reduced fluorescence quenching |
| 12/20/2001 | WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD |
| 12/20/2001 | WO2001096338A1 Non-nucleoside reverse transcriptase inhibitors |
| 12/20/2001 | WO2001096337A1 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds |
| 12/20/2001 | WO2001096336A2 6,5-fused bicyclic heterocycles |
| 12/20/2001 | WO2001096335A1 Imidazo[1,2-a]pyridine ether compounds as ion channel modulators |
| 12/20/2001 | WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096308A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 12/20/2001 | WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096302A1 Piperidines for use as orexin receptor antagonists |
| 12/20/2001 | WO2001095911A1 Protease inhibitors |
| 12/20/2001 | WO2001095910A1 Imidazopyridine and imidazopyrimidine antiviral agents |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 12/20/2001 | US20010053853 Alkanoic acid derivative; integrin receptor antagonist |
| 12/20/2001 | US20010053785 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 12/20/2001 | US20010053784 Imminoribitol PNP inhibitors, preparation thereof and use thereof |
| 12/20/2001 | US20010053779 Antiinflammatory agents; respiratory system disorders |
| 12/20/2001 | US20010053386 (R)-5,6-dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one maleate |
| 12/20/2001 | CA2412632A1 Hmg-coa reductase inhibitors and method |
| 12/20/2001 | CA2412462A1 6,5-fused bicyclic heterocycles |
| 12/20/2001 | CA2412353A1 Protease inhibitors |
| 12/20/2001 | CA2412327A1 Imidazopyridine and imidazopyrimidine antiviral agents |
| 12/19/2001 | EP1164202A1 Mismatch-recognizing molecules |
| 12/19/2001 | EP1164136A1 Long wavelength absorbing bacteriochlorin alkyl ether analogs |
| 12/19/2001 | EP1163242A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 12/19/2001 | EP1163241A1 Zolpidem salts |
| 12/19/2001 | EP1163239A1 Modified amino-acid amides as cgrp antagonists |
| 12/19/2001 | EP1163238A1 Chemokine recpetor binding heterocyclic compounds |
| 12/19/2001 | EP1162970A2 Anti-inflammatory uses of manzamines |
| 12/19/2001 | EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/19/2001 | EP0912573B1 Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents |
| 12/19/2001 | EP0859778B1 TETRAHYDROIMIDAZOPYRIDOINDOLEDIONES AS INHIBITORS OF cGMP SPECIFIC PDE |
| 12/19/2001 | EP0781281B1 Beta-carboline derivatives as melatonin agonists, methods for their preparation and their use as drugs |
| 12/19/2001 | CN1327468A Organic electroluminescent element |
| 12/19/2001 | CN1326934A 1,7-twice substituted perylene-3,4,9.10-tetracarboxylic acid diimide |
| 12/19/2001 | CN1326803A Reaction crystallizing method for improving grain size |
| 12/19/2001 | CN1076369C Solid solutions of 1,4-diketopyrrbopyrroles |
| 12/18/2001 | USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
| 12/18/2001 | US6331548 Prevention or treatment of cytokine related diseases |
| 12/18/2001 | US6331543 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 12/18/2001 | US6331541 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/18/2001 | US6331539 Sulfonamide and sulfamide substituted imidazoquinolines |
| 12/18/2001 | US6331538 Treatment of bacterial infection |
| 12/18/2001 | US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 12/18/2001 | CA2166470C Pharmacologically active enantiomers |
| 12/18/2001 | CA2082923C Sulfonyl compounds |
| 12/13/2001 | WO2001094351A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | WO2001094347A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/13/2001 | WO2001094346A1 1,3,8-TRIAZA-SPIRO'4,5!DECAN-4-ONE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS |
| 12/13/2001 | WO2001094345A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 12/13/2001 | WO2001055719A3 Diagnostic kit for detecting creatine levels |
| 12/13/2001 | US20010051732 3-urea compound from the 3-amido compound without azidation process which has risk of explosion; reaction with hypochlorite, hypobromite or lead tetraacetate and then an amine; ACAT inhibitor |
| 12/13/2001 | US20010051718 Reacting a 3 substituted 2-amino-pyridine with N-methyl-1-phenyl-2,2'-iminodiethyl halide, then adding ring closing agent to form mirtazepine; antidepressant |
| 12/13/2001 | US20010051633 E.g.,N-((4-amino-3-nitrophenoxy)ethyl)-1,2,3,4-tetrahydro -isoquinoline; stroke; antiischemic agents; CNS trauma, hyperglycemic agents; surgery; neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis |
| 12/13/2001 | US20010051632 Histamine H3 receptor antagonists; central nervous system disorders; Alzheimer's disease; antiepileptic agents; eating disorders; motion sickness; attention deficit hyperactivity disorder; cognition activators; schizophrenia |
| 12/13/2001 | US20010051631 E.g., 1,2-dihydro-1-(2-(1-trifluoromethanesulfonylpiperidin-ethane-1 -yl)-1,4,7b-triazacyclopent(cd)inden-2-one; platelet-derived growth factor inhibitor; hypotensive and antilipemic agents; urogenital disorders |
| 12/13/2001 | US20010051627 Substituted 2-(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)- 4(3H)-azaquinazolinones |
| 12/13/2001 | US20010051620 Tricyclic protein kinase inhibitors |
| 12/13/2001 | DE10001037C1 Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen Processes and intermediates for the preparation of imidazopyridines |
| 12/13/2001 | CA2411010A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/13/2001 | CA2409015A1 Caspase inhibitors and uses thereof |
| 12/12/2001 | EP1161432A1 Pharmaceutical composition based on polyaromatic compounds |
| 12/12/2001 | EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors |
| 12/12/2001 | EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/12/2001 | EP0767790B1 Condensed imidazole compounds, their production and use |
| 12/12/2001 | EP0663912B1 Heterocyclic ether compounds that enhance cognitive function |
| 12/12/2001 | CN1326458A CRF receptor antagonists and methods relating thereto |
| 12/11/2001 | US6329520 Used as imaging or pharmaceutical agents, in the diagnosis and treatment of drug addiction, depression, anorexia and neurodegenerative diseases or in determining doses of therapeutic agents that occupy many receptors |
| 12/11/2001 | US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 12/11/2001 | US6329394 Medical use for tachykinin antagonists |
| 12/11/2001 | US6329391 Antibiotics, bactericides using quinolones |
| 12/11/2001 | US6329390 5-Bicycloindole compounds |
| 12/11/2001 | US6329389 Amine compounds, their production and use |
| 12/11/2001 | US6329387 Use of thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
| 12/11/2001 | US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders |
| 12/11/2001 | US6329380 Pyrimidine benzimidizazole, pyrimidineimidazole or pyridine imidazole compounds for anticancer agents or atherosclerosis |
| 12/11/2001 | US6329363 Cephalosporin antibiotics |
| 12/11/2001 | CA2226292C Substituted benzolactam compounds as substance p antagonists |
| 12/06/2001 | WO2001092261A1 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof |
| 12/06/2001 | WO2001092260A1 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof |
| 12/06/2001 | WO2001092259A1 1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof |
| 12/06/2001 | WO2001092258A1 Imidazoloisoquinolines |
| 12/06/2001 | WO2001092257A1 Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands |
| 12/06/2001 | WO2001092256A1 2,7-naphthyridine derivatives |
| 12/06/2001 | WO2001091752A1 Melanocortin receptor agonists |